LOS ANGELES – Agritek Holdings, Inc. (AGTK), a completely built-in, lively actual property investor and its wholly owned subsidiary Full Spectrum Biosciences Inc., an IP, formulation and white label supplier for fashionable hemp manufacturers RehabRx and Hemp Pops, immediately introduced that Full Spectrum Biosciences and California based mostly Biomedican Inc. have executed a Letter of Intent and are finishing a three way partnership settlement for the primary take a look at pilot program utilizing Biomedican’s patented biosynthetic strategies utilizing yeast fermentation, to make sure the environment friendly manufacturing of high-quality cannabinoid profiles and compounds.

As featured in Forbes, Nasdaq and Axios, Biomedican generates cannabinoids and terpenes instantly from proprietary yeast with out expensive plant cultivation or inefficient extraction and purification procedures in a scalable course of and operation. Production amenities for biosynthesis price a fraction of conventional hashish cultivation and extraction amenities, enabling far more cost-efficient manufacturing inside an authorized laboratory setting.

In distinction to chemically synthesized compounds, the Biomedican pure, natural, non-GMO biosynthetic merchandise are an identical to these extracted from crops whereas providing larger purity than usually present in nature. In addition, the distinctive proprietary yeast is optimized to produce larger portions of product at decrease price than competing biosynthetic strategies presently being utilized.

By the numbers: According to a current analysis observe from Raymond James, the worldwide cannabinoid biosynthesis market forecasted to be $10 billion by 2025. Quite a few startups are transferring into the biosynthesized cannabinoid area, which Raymond James analyst Rahul Sarugaser has written is “synthetic biology’s next killer app.”

The typical technique of acquiring cannabinoids like CBD entails cultivating hashish crops that comprise the pressure needed, after which extracting the specified chemical substances. Because among the most in-demand cannabinoids happen in very low concentrations in nature, quite a lot of plant matter is required, which implies manufacturing prices could be a number of thousand {dollars} per kg.

“We are extremely excited to be entering the joint venture with Biomedican and to be one of the few companies chosen for the test pilot program for yeast generated synthetic cannabinoids for our nutraceutical and edible lines as IP of Full Spectrum Biosciences. This is truly next generation science within the cannabis sector and we hope our result driven research through this biosynthesis test pilot program and partnership with Biomedican allows the world wide nutraceutical and big pharma industries to take notice,” said B. Michael Friedman CEO.

“Biomedican has the highest quality and lowest production costs in the industry, which makes us the perfect partner for companies that have large distribution networks in CBD, nutraceuticals, health food, cosmetics and pet care to add our compounds into current products and build new product lines. Agreements like these will deliver turnkey global distribution for Biomedican,” says Dennis O’Neill, CIO of Biomedican.

In biosynthesis, microbes like yeast and micro organism are engineered to produce giant portions of a single cannabinoid in a fermentation course of that works equally to beer brewing. As a consequence, biosynthesis firms like Biomedican and Full Spectrum Biosciences shall be in a position to produce costly CBD, CBG, CBN cannabinoids at a a lot cheaper price and with out fears of contamination and numerous components related to out of doors/indoor cultivation and enormous scale develop operations.

The Future of Rare Cannabinoids

“Soon, CBD will become an afterthought as more potent cannabinoids replace it in medicine, beauty products, food and beverages, and more. Rare cannabinoids like CBG, THCA, CBN, THCV, and more will all contribute to this shift, with CBG being the most highly desired for its versatile applications in both the pharmaceutical and food/beverage industries. Together, these rare cannabinoids will be the new frontier that may makes the global cannabis market a multi-billion dollar sector. CBG will be at the forefront of this rare cannabinoid boom,” said Maxim Mikheev, CEO and Founder of Biomedican.

The new Full Spectrum Biosciences and Biomedican take a look at pilot program will search to streamline the manufacturing pipeline of pure and constant yeast based mostly cannabinoid compounds, together with: CBG, THCA and CBN which can be anticipated to be in excessive demand by huge pharma and the nutraceutical industries throughout many areas inside the U.S. and Canada. The Company expects to full the three way partnership settlement and begin the take a look at pilot program earlier than the 12 months finish and can collectively search extra funding by means of Agritek’s institutional funding advisors to increase manufacturing nationally.

The international CBD market is anticipated to attain USD 146.four billion by the top of 2025, in accordance to a brand new report by Grand View Research, Inc. Growing adoption of marijuana in a number of medical functions resembling most cancers, psychological problems, power ache and others is anticipated to propel income development in close to future.

Browse full analysis report with TOC on “Legal Marijuana Market Size, Share & Trends Analysis Report By Type (Medical, Recreational), By Product Type, By Medical Application (Chronic Pain, Mental Disorders, Cancer), And Segment Forecasts, 2018 – 2025” at: https://www.grandviewresearch.com/industry-analysis/legal-marijuana-market

Increasing variety of firms working within the marijuana market is anticipated to bolster the amount and number of merchandise reaching the top customers. Products like marijuana oil have began gaining traction over the previous few years owing to elevated effectiveness and security as in contrast to smoking it. Also, the rising analysis within the hashish trade has led to introduction of recent marijuana strains. These advances in new product growth is anticipated to improve product adoption amongst customers. Legal marijuana market is witnessing robust technological and knowledge change. Countries like Canada, the U.S., Germany and Australia are anticipated to emerge as main markets when it comes to gross sales, whereas nations like Israel are specializing in analysis and expertise growth and are leveraging information switch.

Further Key Findings From the Report Suggest:

  1. The U.S. authorized marijuana market dimension was estimated at USD 7.06 billion in 2016 and is anticipated to develop at a CAGR of 24.9% from 2017 to 2025
  2. Medical marijuana emerged as the biggest marijuana sort section in 2016 and is estimated to be valued at USD 100.03 billion by 2025
  3. By product sort, marijuana buds section was estimated to be dominant in 2016 with income share of 62.9% and is estimated to be valued at USD 82.9 billion by finish of 2025
  4. Some gamers working in authorized marijuana market embody; Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., Tilray, The Cronos Group, Organigram Holdings, Inc, ABcann Medicinals, Inc., and Tikun Olam

About Agritek Holdings, Inc. and Full Spectrum Biosciences
Agritek Holdings, Inc., is a completely built-in, lively actual property investor and advisor of white label manufacturers within the authorized hashish sector. Specifically, Agritek Holdings gives strategic capital and practical experience to speed up the commercialization of its diversified portfolio of hashish associated actual property holdings. The hemp based mostly uncooked materials and merchandise produced at amenities owned by Agritek Holdings and leased again to licensed operators are then used for retail branded CBD, CBG and Hemp oil extract merchandise produced by its subsidiary Full Spectrum Biosciences presently bought through e-commerce, on-line, Amazon and Doctors places of work inside the United States. Brands embody RehabRX, Hemp Pops, MD Vapes, and a number of white labeled manufacturers. Agritek Holdings Inc. doesn’t instantly develop, harvest, or distribute or promote hashish or any substances that violate or contravene United States legislation or the Controlled Substances Act.

About Biomedican
Biomedican is a California based mostly life sciences firm that generates cannabinoids and terpenes instantly from proprietary yeast with out expensive plant cultivation or inefficient extraction and purification procedures in a scalable course of and operation. Production amenities for biosynthesis price a fraction of conventional hashish cultivation and extraction amenities enabling far more cost-efficient manufacturing inside an authorized laboratory setting. The Company’s proprietary expertise can revolutionize the cannabinoid provide chain and instantly feed into a number of markets the place cannabinoids and terpenes are in excessive demand.

The pharmaceutical potential of cannabinoids can’t be overstated, because the efficacy of cannabinoids has been implicated in treating pathologies with billion-dollar markets within the U.S. alone. The Company lately featured in Forbes, Nasdaq and Axios said their patented course of and low-cost manufacturing of such high-value compounds might generate a aggressive benefit over conventional types of therapy for diabetes, cancers, autoimmune problems, respiratory illness, nervous system problems, ache, viruses, ADHD, and extra.

Source link